注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
NeuroMetrix Inc专注于开发和商业化利用非侵入性神经刺激的保健产品。该公司从事设计、制造和营销用于诊断和治疗目的的刺激神经和分析神经反应的医疗设备。它有两个主要产品类别,包括即时神经病变诊断测试和可穿戴神经刺激设备。该公司的产品包括DPNCheck、Quell和ADVANCE 系统。DPNCheck是一种定量神经传导测试,用于评估周围神经病变,例如糖尿病周围神经病变 (DPN)。Quell是一种可穿戴设备,用于缓解症状和管理慢性疼痛。ADVANCE系统是进行神经传导研究的平台。DPNCheck的客户包括管理式医疗机构、内分泌学家、足病医生和初级保健医生。 ADVANCE系统的客户涵盖职业健康、初级保健、内科等。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Shai N. Gozani | 56 | 1996 | Founder, Chairman, CEO, President & Secretary |
Jiro Nakamura | - | 2014 | Member of Scientific Advisory Board |
David E. Goodman | 66 | 2004 | Independent Director |
Bradley M. Fluegel | 61 | 2022 | Independent Director |
Arthur I. Vinik | - | 2011 | Member of Scientific Advisory Board |
Solomon Tesfaye | - | 2011 | Member of the Scientific Advisory Board |
Bruce A. Perkins | - | 2011 | Member of the Scientific Advisory Board |
Neil H. Brooks | - | 2011 | Member of the Scientific Advisory Board |
Nancy E. Katz | 64 | 2010 | Independent Director |
Dan Ziegler | - | 2011 | Member of the Scientific Advisory Board |
Andrew J.M. Boulton | - | 2011 | Member of the Scientific Advisory Board |
David G. Armstrong | - | 2011 | Member of the Scientific Advisory Board |
David Van Avermaete | 72 | 2013 | Independent Director |
Joshua S. Horowitz | 46 | 2024 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核